Real-time enrollment status for this lung cancer clinical trial
Current Status
Recruiting
Checked: October 21, 2026 at 10:07 PM UTC
| NCT Number | NCT06561386 |
| Recruiting Status | Recruiting |
| Condition | Lung Cancer |
| Phase | PHASE3 |
| Target Enrollment | 1,000 participants |
| Active Locations | 56 sites in the US |
| Sponsor | Bristol-Myers Squibb |
| Last Updated on CT.gov | September 23, 2026 (4 weeks ago) |
As of October 21, 2026: Clinical trial NCT06561386 is currently recruiting participants. This phase3 study for lung cancer is actively seeking new participants at 56 locations across the United States. The study is sponsored by Bristol-Myers Squibb. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06561386 is actively recruiting participants as of October 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 56 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06561386 was last updated 4 weeks ago (September 23, 2026). HelloStudys verifies this status automatically.